CRP has gained recognition as a diagnostic and prognostic marker for various conditions, including autoimmune diseases, cardiovascular diseases, chronic kidney disease, cancer, and infectious diseases. As a readily measurable biochemical marker, CRP can aid in risk stratification and inform therapeutic management for patients with APE [16,22]. Here, CRP is linked to apparent mineralocorticoid excess.